Effects of Health Education on Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting among Community Pharmacists in Anambra State, Nigeria
Churchhill O. Osagie
College of Postgraduate Studies, Nnamdi Azikiwe University Nnewi, Nigeria and Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Chinomnso C. Nnebue
*
Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Chijioke A. Ezenyeaku
Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Martin N. Okolie
Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Abuchi E. Nwafia
College of Postgraduate Studies, Nnamdi Azikiwe University Nnewi, Nigeria and Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Ifeoma B. Udigwe
Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Achunam S. Nwabueze
Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Chika F. Ubajaka
College of Postgraduate Studies, Nnamdi Azikiwe University Nnewi, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Background: Poor reportage of adverse drug reaction has been linked o. increase in morbidity, mortality and economic burden of diseases and health related conditions.
Objective: To determine the effects of health education on knowledge, attitude and practice of adverse drug reaction (ADR) reporting among community pharmacists practicing in Anambra State.
Methods: This interventional study was conducted among Community Pharmacists in Anambra State. Simple random samp\ling technique was used. Pre-tested, semi-structured self-administered questionnaire was used to collect data on respondents’ socio-demographics, knowledge of, attitude to and practice of ADR reporting Associations between variables were tested using Chi-square and Binary logistic regression at 5% level of significance. Data obtained were analyzed using SPSS version 23.
Results: The mean age of the respondents was 46.5±11.2 years. Post intervention result shows that there was an increase in knowledge of ADR reporting in the intervention group from 52% to 95.3%. There was a decrease in knowledge of ADRs reporting in the control group from 47.3% to44.7%. There was a statistically significant difference between the experimental group and the control group on their attitude towards ADR reporting (p<0.05). Only 26.7% of the test group had filled a spontaneous reporting ADR form prior to this study compared to 18% from the control group and is associated with the effect of health education intervention.
Conclusions: There was underreporting of ADRs, associated with gaps in the knowledge, attitude and practice among the community pharmacists studied. There is need for focused continuous health education interventions on ADR reporting among them.
Keywords: Health education, reporting, adverse drug reaction Nigeria, community pharmacists
How to Cite
References
Johnson SS, Fakeye TO. The concept of adverse drug reaction reporting: awareness among pharmacy students in a Nigerian university. Internet Journal of Medical Update. 2013;8(1):24-30.
Agu KA, Oparah AC, Ochei UM. Improving monitoring and reporting of adverse drug reactions (ADRs) in HIV positive patients on antiretroviral therapy (ART) in Nigeria. Journal of Basic and Clinical pharmacy. 2012;3(2):299-313.
Kiguba R, Karamagi C, Waako P, Ndagije HB, Bird SM. Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants. BMJ Open. 2014;4(11):5869.
Fadare JO, Okezie OE, Afolabi AO. Knowledge, attitude and practices of adverse drug reaction reporting among health care workers in a tertiary centre in Northern Nigeria. Tropical Journal of Pharmaceutical Research. 2011;10(3):235-242.
Oreagba IA, Ogunleye OJ, Olayemi SO. The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria. Pharmacoepidemiology and Drug Safety Journal. 2011;20(1):30-35.
Isah AO. 5–year Pharmacovigilance Plan for Nigeria 2007 – 2011. Available at: Available:http://www.who.int/prequal/trainingresources/pq_pres/pharmacovigilance/Country_Presentation/NIGERIA.ppt). (Accessed on Feb 16 2018).
Ramezani TB, Javid NN. Report of the Iranian Pharmacovigilance Center. Razi Journal. 2007;12:85–90.
Sriphiromya P, Theeraroungchaisri A. An analysis of legal warnings after drug approval in Thailand. Regulatory Toxicology and Pharmacology. 2015; 71:108–113.
Greene S, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Annals of Pharmacotherapy. 2012;46(2): 169–175.
Falconer N, Barras M, Cottrell N. Systematic review of predictive risk models for adverse drug events in hospitalized patients. British Journal of Clinical Pharmacology. 2018;84(5):846-866.
Miller R, Goodman C. Performance of retail pharmacies in low- and middle-income. Asian settings: a systematic review, Health Policy and Planning. 2016; 31(7):940–953.
Kenneth AA, Azuka CO, Uche MO. Improving monitoring and reporting of adverse drug reactions (ADRs) in HIV positive patients on antiretroviral therapy (ART) in Nigeria. Journal of Basic and Clinical Pharmacy. 2012;1(15):299-302.
Radhakrishnan R, Sudha V, Danturulu MV. An educational intervention to assess knowledge, attitude and practice of pharmacovigilance among health care professionals in an Indian tertiary care teaching hospital. International Journal of PharmTech Research. 2011;3(2):678-692.
Anambra State Government. History of Anambra State.
Available:http://www.anambrastate.gov.ng/history (Accessed on 12 April, 2018)
Pharmacists Council of Nigeria. Brief history. Available:http://www.pcn.gov.ng/webpages.php?cmd=N&pages=2&mt=Registry&smt=Brief%20History. (Accessed on 12 April, 201
Kirkwood BR, Sterne JA. Essential Medical Statistics 2nd edition. Massachusetts: Blackwell Science; 2003.
Bisht M, Singh S, Dhasmana DC. Effect of educational intervention on adverse drug reporting by physicians: A Cross-Sectional Study. ISRN Pharmacology. 2014;259476: 1-8.
United State Agency for International Development. Strengthening pharmaceutical systems. Supporting pharmacovigilance in developing countries. The system perspective. 2009;2-5. Available:httpapps.who.int/medicinedocs/en/cl/CL8.3.2.5/clmd,50.html (Accessed 14 Feb, 2018)
Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation and reporting. Annals of Internal Medicine. 2004;140:795-801.
Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysa. Pharmacoepidemiology Drug Safety. 2007; 6:223–228.
Pirmohamed M, Peter W, Kwam NA, Alex NO. Pharmacovigilance in developing countries. British Medical Journal. 2007; 335: 462 Pirmohamed M, Peter W, Kwam NA, Alex NO. Pharmacovigilance in developing countries. British Medical Journal. 2007;335:462
Duarte M, Ferreira P, Soares M, Cavaco F, Martins A. Community pharmacists’ attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study. Drugs and Therapy Perspectives. 2015;31:316.
Khan SA, Goyal C, Chandel N, Rafi1 M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. Journal of Natural Science, Biology and Medicine. 2013;4(1): 191–196.
Ramesh M, Parthasarathi G. Adverse drug reactions reporting: Attitudes and perceptions of medical Practitiner. Asian Journal Pharmaceutical Clinical Research. 2009;2:18
International Business Machine-Statistical package for social sciences (IBM-SPSS) 22.0 version. Armonk NY: IBM United States: IBM Corp; 2013.
Staniszewska A, Dąbrowska-Bender M, Olejniczak D, Duda-Zalewska A, Bujalska-Zadrożny M. Patient knowledge on reporting adverse drug reactions in Poland. Patient Prefer Adherence. 2016;11:47–53.
Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharmacy World Science. 2008;30:556–562.
Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharmacy World Science. 2009;31:183–187
Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiology Drug Safety. 2010; 19:217–222.
Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clinical Pharmacology and Toxicologyy. 2008;102:408–411.
Suyagh M, Farah D, Abu-farha R. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharmaceutical Journal. 2015; 23:147–153.
Mahmoud MA, Alswaida Y, Alshammari T, Khan TM, Alrasheedy A, Hassali MA, et al. Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharmaceutical Journal. 2014;22: 411–418.
Abdel-Latif MM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharmaceutical Journal. 2014;23:154–161.
Subish P, Mohamed Izham M, Mishra P. Evaluation of the knowledge, attitude and practices on adverse drug reactions and pharmacovigilance among health¬care professionals in a Nepalese hospital-a preliminary study. Internet Journal of Pharmacology. 2008;6(1).
Raymond CO, Sunday OO, Grace NE, Mattew JO. Awareness, Attitude and Practice of pharmacovigillance among health care professionals in Nigeria. International Journal of Hospital Research. 2013;2(3):99-108.
Mohamed A, Abdel-Wahab B. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals In: Al-Madinah, Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharmaceutical Journal. 2014; (23)2:154-161.
Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharmaceutical Journal. 2017;25: 830–837.
Jose J, Jimmy B, Al-Ghailani AS, Al Majali MA. A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman. Saudi Pharmaceutical Journal. 2014;22:163-169.
Okezie OO, Fawole OL. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug safety. 2008;17(1):517-522.
Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clinical Pharmacology. 2009;9:14
Herdeiro MT, Pineiro-Lamas M, Figueiras A, Group G. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug Safety. 2015; 38:189–196.
Rajesh R, Vidyasagar S, Varma DM. An educational intervention to assess knowledge attitude practice of pharmacovigilance among healthcare professionals in an Indian tertiary care teaching hospital. International Journal of Pharmtech Research. 2011;3:678–692.
Afifi S, Maharloui N, Peymani P, Namazi S, Gharaei AG, Jahani P, et al. Adverse drug reactions reporting: pharmacists’ knowledge, attitude and practice in Shiraz, Iran. Int. J. Risk and Safety in Medicine. 2014;26:139–145
Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: knowledge attitudes and perceptions amongst resident doctors. Journal of Pharmaceutical Sciences and Research. 2011;3:1064–1069.
Iffat W, Shakeel S, Rahim N, Anjum F, Neesar S, Ghayas S. Pakistani physicians’ knowledge and attitude towards reporting adverse drug reactions. African Journal of Pharmacy and Pharmacology. 2014;8: 379–385.
Bakhsh TM, Al-Ghamdi MS, Bawazir SA, Omer TY, Qureshi N. Assessment of hospital physicians’ knowledge, awareness, attitude and practice of reporting adverse drug reactions in Jeddah, Saudi Arabia. British Journal of Medicine and Medical Research. 2016; 16:1–16.
Alves de Araújo-Lobo MG, Botelho-Pinheiro SM, Díaz-Castro JG, Momenté VG, Pranchevicius MS. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC Pharmacology and Toxicology, 2013;14(1):1
Goyal M, Bansal M, Yadav S, Grover V. To assess the attitude, knowledge and practices of medical professionals about adverse drug reactions and their reporting in a teaching hospital. Indian Journal of Clinical Practice. 2013;24(3):281-284.